Tag: platform

BURNABY, B.C. - MIAMISBURG, Ohio -, June 15, 2026 (GLOBE NEWSWIRE) -- Novarc Technologies Inc., the industrial Physical AI company reinventing welding automation for the global fabrication industry, today announced the company has signed a Memorandum of Understanding (MoU) with Yaskawa America, Inc. (Motoman Robotics Division) to bring Novarc’s AI-powered adaptive welding intelligence platform to the Yaskawa robotic platform.

IRVINE, Calif., June 15, 2026 (GLOBE NEWSWIRE) -- Clean Energy Technologies, Inc. (“CETY” or the “Company”) (Nasdaq: CETY), a clean energy technology company focused on sustainable energy and waste-to-value solutions, today announced the successful implementation of its advanced ORC component manufacturing initiative, which should substantially reduce production costs and improve supply chain efficiency for the Clean Cycle II (“CCII”) heat recovery systems.

Integration brings deeper audience intelligence to out-of-home planning, targeting and campaign performance across Quebecor’s Out-of-Home network

WEST PALM BEACH, Fla., June 15, 2026 (GLOBE NEWSWIRE) -- Sunrise Realty Trust, Inc. (Nasdaq: SUNS) (“SUNS” or the “Company”), a lender on the Tannenbaum Capital Group (“TCG”) Real Estate platform, today announced its dividend for the quarter ending June 30, 2026.

FREMONT, Calif., June 15, 2026 (GLOBE NEWSWIRE) -- Enphase Energy, Inc. (NASDAQ: ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, today announced the appointment of Shanker Trivedi to its board of directors, effective immediately.

Anadarko Basin project pairs continued American oil production with permanent CO₂ storage — Blue Energy’s first U.S. operation and the foundation of a new Carbon-Neutral Division

MELBOURNE, Australia, June 15, 2026 (GLOBE NEWSWIRE) -- ENA Respiratory, a clinical-stage pharmaceutical company developing innate immune modulators for the prevention of complications associated with respiratory viral infections in at-risk populations, announces today that it has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for two patent applications, notably a composition-of-matter patent and method-of-use for its Toll-like receptor 2 (TLR2) therapies.